Bosutinib (SKI-606)
Bosutinib (SKI-606) is a novel tyrosine kinase inhibitor. Bosutinib can overcome not only Bcr-Abl-dependent mechanisms of resistance, but also those that are Bcr-Abl-independent. It is used to treat patients with chronic myelogenous leukemia (CML) who demonstrate resistance to Imatinib or develop resistance during treatment.
Product Specifications
Shipping Conditions
RT
Storage Conditions
-20°C
Shelf Life
24months
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15154813 1 Vial
Lentiviral human HOXD13 shRNA (UAS) - Lentiviral human HOXD13 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
MBS1407726-01 0.02 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua UPF0352 protein YPN_2715 (YPN_2715)
Sign In for Pricing
View Details MBS1407726-02 0.1 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua UPF0352 protein YPN_2715 (YPN_2715)
Sign In for Pricing
View Details